Merck Sharp & Dohme LLC vs. Halozyme, Inc. et al.
Explore the PTAB proceeding PGR2025-00024 filed by Merck Sharp & Dohme LLC on 2025-02-21. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
PGR2025-00024
Filing Date
2025-02-21
Accorded Filing Date
2025-02-21
Institution Decision Date
2025-10-16
Last Modified Date
2026-10-15
Proceeding Type
PGR
Termination Date
2026-10-15
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Merck Sharp & Dohme LLC
Represented By
Kushan, Jeffreyet alPatent Owner / Respondent
Halozyme, Inc. et al.
Represented By
Ellison, Eldoraet alTribunal & Venue
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Patent Information
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 31066 | Gary Williams | 650-843-7501 |
| 37386 | Michael Lyons | 650-843-7507 |
| 39266 | Soyeon Laub | 714-830-0512 |
| 39951 | Douglas Crisman | 650-843-4000 |
| 40506 | Louis Beardell Jr | 215-963-5067 |
| 41040 | Robert Goodell | 202-739-5549 |
| 41796 | Andrew Gray Iv | 650-843-4000 |
| 42223 | Jason White | 312-321-4200 |
| 42813 | Brett Lovejoy | 415-442-1211 |
| 42837 | Jeffry Mann | 415-442-1000 |
| 43378 | Collin Park | 202-739-3000 |
| 44146 | Brent Hawkins | 415-442-1000 |
| 45645 | Dion Bregman | 650-843-4000 |
| 46692 | Ramyar Farid | 202-739-5195 |
| 50801 | Robert Smyth | 202-739-5139 |
| 50862 | Ahren Hsu-Hoffman | 650-843-4000 |
| 50891 | Jeffrey Killian | 202-739-5592 |
| 51793 | Mark Hayman | 617-951-8440 |
| 53615 | Nathan Smith | 949-757-6018 |
| 55202 | Jason Gettleman | 650-843-7593 |
| 55293 | Ari Indik | 215-864-7138 |
| 56890 | Christopher Betti | 312-324-1449 |
| 57765 | Yalei Sun | 650-843-7558 |
| 58729 | Louis-Vu Nguyen | 415-442-1303 |
| 58752 | John Hemmer | 215-963-4816 |
| 59462 | Brad Wilson | 312-324-1103 |
| 59649 | Tae Woong Koo | 650-843-7246 |
| 60472 | M. Hales | 714-830-0514 |
| 60711 | Richard Leung | 215-963-5082 |
| 61841 | Kenneth Cheney | 714-830-0526 |
| 63115 | Michael Ryan | 610-574-1318 |
| 63133 | Stephen Altieri | 617-951-8525 |
| 63328 | Clay Hawes | 7034154864 |
| 64526 | Janice Logan | 202-439-5234 |
| 65210 | Christina Macdougall | 415-442-1277 |
| 65452 | Kelly Plummer | 312-324-1490 |
| 65592 | Liying Sun | 650-843-7215 |
| 66838 | Jianbai Wang | 650-843-7843 |
| 67084 | Maria Doukas | 312-324-1454 |
| 67908 | Yingying Zhou | 415-442-1214 |
| 67961 | Tairan Wang | 202-739-5119 |
| 68345 | Danny Mansour | 714-830-0600 |
| 68487 | Alia Orbin | 610-390-7234 |
| 69096 | Toyomi Ohara | 202-739-3000 |
| 69232 | Rachna Ram | 510-524-1579 |
| 69316 | Byung Cheol Kwak | 617-341-7264 |
| 69333 | Hosang Lee | 202-937-5142 |
| 70067 | Sujohn Das | 713-890-5792 |
| 70236 | Kalpesh Upadhye | 202-739-5157 |
| 70711 | Benjamin Pezzner | 650-843-4000 |
| 70871 | Andrew Antczak | 215-963-5000 |
| 71054 | Yon Sohn | 858-587-1121 |
| 71064 | David Bernstein | 650-843-4000 |
| 71076 | Wan-Shoon Lo | 312-984-5810 |
| 71397 | Alexander Stein | 650-843-7278 |
| 71751 | Moreshwar Vaze | 617-341-7952 |
| 71783 | Nicholas Restauri | 312-324-1000 |
| 72445 | Jianke Kang | 202-739-5183 |
| 73464 | Hang Zheng | 202-585-8307 |
| 73683 | Amanda Williamson | 312-324-1450 |
| 73696 | Chantal Edde | 215-963-5656 |
| 74139 | Ka Lo Yeh | 650-843-7815 |
| 74539 | Sadie Knight | 415-442-1000 |
| 74630 | Victor Ghidu | 215-963-5719 |
| 75253 | Alyssa Pugh | 215-963-5070 |
| 75470 | Sara Sims | 215-963-5630 |
| 75669 | Andrew Dietrick | 570-906-0745 |
| 75688 | Emily Coury | 617-341-7818 |
| 75724 | Alexandra Koseva | 650-843-7211 |
| 75810 | Matthew Walker | 206-274-6374 |
| 75815 | Catherine Chou | 650-843-4000 |
| 76003 | Drew Bennett | 617-341-7833 |
| 76140 | Alexandria Petterson | 650-843-7841 |
| 76203 | Calvin Brien | 202-739-5167 |
| 76671 | Andrew Devkar | 310-255-9070 |
| 77267 | Ai Leen Koh | 650-843-7823 |
| 77446 | Theodore Rand | 650-843-7275 |
| 77698 | Phillip Wolfe | 215-963-5454 |
| 77918 | Alicia Fraind | 215-972-8594 |
| 77996 | Min Woo Park | 202-673-95697 |
| 78072 | Conor Ball | 415-442-1668 |
| 78272 | Sandhal Olds | 765-618-4658 |
| 79029 | Alexander Harrison | 404-815-6046 |
| 79060 | Kannan Narayanan | 408-685-3658 |
| 79300 | Evelyn Chou | 415-442-1609 |
| 79663 | Kathryn Chesnick | 570-878-2384 |
| 79760 | Xiaoqian Li | 650-843-7853 |
| 79839 | Peter Loderup | 714-830-0517 |
| 79856 | Timmy Lee | 650-843-7517 |
| 80363 | Yuqi Li | 215-564-3236 |
| 80469 | Alec Mandell | 650-843-7228 |
| 80622 | Corey Moore | 617-341-7852 |
| 80944 | Hye Hyun Ahn | 202-434-7300 |
| 81040 | Eunjean Je | 202-739-5929 |
| 81210 | Hayley Reed | 215-963-4957 |
| 81433 | Kurosu Altaf | 650-843-7233 |
| 81482 | Pablo Herrera Jr. | 650-843-7512 |
| 81484 | Samantha Kuo | 714-579-5530 |
| 81604 | Xinming Zhang | 415-442-1392 |
| 81935 | Jia Jie Tang | 617-951-8000 |
| 81982 | Corine Martineau | 215-963-5030 |
| 82004 | Isabella Couture | 316-680-1931 |
| 82139 | Xuedong Zhu | 857-333-6217 |
| 82373 | Alyssa Galvin | 202-739-5786 |
Proceeding Documents
200Final Written Decision: original FINAL
Other: Hearing transcript OTHER
MSD LLC v. Halozyme - Petitioner Demonstratives (Part 4 Slides 131-194) Exhibit
MSD LLC v. Halozyme - Petitioner Demonstratives (Part 2 Slides 51-65) Exhibit
MSD LLC v. Halozyme - Petitioner Demonstratives (Part 3 Slides 66-130) Exhibit
MSD LLC v. Halozyme - Petitioner Demonstratives (Part 1 Slides 1-50) Exhibit
Petitioner's Updated Exhibit List NOTICE
Patent Owner's Updated Mandatory Notices NOTICE
EX2500 - Patent Owner's Demonstratives for Oral Argument Exhibit
Patent Owner's Updated Exhibit List NOTICE
Email_Request for DR Denying PO's Motion to Terminate_Dismissed Exhibit
EX2300 - Naismith Declaration Errata Exhibit
EX2302 - Kelsoe Deposition Transcript Exhibit
EX2301 - Naismith Deposition Transcript Exhibit
Patent Owner's Sur-Reply OTHER
EX2215 - Khurana 2011 Exhibit
EX2304 - Naismith Deposition Transcript 2026-06-13 Exhibit
EX2303 - PGR2025-00046 EX1133 - Naismith Declaration Exhibit
Patent Owner's Request for Director Review of Order Denying Motion to Terminate (PUBLIC - REDACTED) OTHER
Patent Owner's Updated Mandatory Notices NOTICE
Email, Subject_Merck v. Halozyme PGRs __ Filing of Request for Director Review Exhibit
Deposition Transcript of Kelly Grez Exhibit
Patent Owner's Brief on Testimony of Ms. Kelly Grez (PUBLIC - UPDATED REDACTIONS) OTHER
Public Order Denying Motion to Terminate OTHER
Patent Owner's Sixth Motion to Seal MOTION
ORDER Granting Petitioner’s Motion to Seal 37 C.F.R. §§ 42.14, 42.54 ORDER
Order: Conditionally Granting PO's Motion to Seal ORDER
Order: ORDER Setting Oral Argument 37 C.F.R. § 42.70 ORDER
Patent Owner's Objections to Evidence OTHER
EX2214 - Summers PTAB Declaration Exhibit
Patent Owner's Updated Mandatory Notices NOTICE
Patent Owner's Updated Power of Attorney NOTICE
Patent Owner's Notice of Intent to Designate Provisionally Recognized PTAB Attorney as Back-up Counsel NOTICE
Patent Owner's Updated Exhibit List NOTICE
Primakoff, P. et al., “Purification of the guinea pig sperm PH-20 antigen and detection of a site-specific endoproteolytic activity in sperm preparations that cleaves PH-20 into two disulfide-linked fragments,” Biology of Reproduction 38:921-934 (1988) Exhibit
Chiti et al., “Studies of aggregation of mutant proteins in vitro provided insights into genetics of amyloid diseases” PNAS 99:16419-26 (2002) Exhibit
Van Rossum et al., “Reporter-based screening and selection of enzymes” FEBS J. 280:2979-96 (2013) Exhibit
Nikolova E. et al., “All Forms of Human IgA Antibodies Bound to Antigen Interfere with Complement (C3) Fixation Induced by IgG or by Antigen Alone,” Scand J Immunol., 39(3):275-80 (1994) Exhibit
Wang et al., “Immunogenicity of protein aggregates-Concerns and Realities” Int. J. Pharmaceutics 431:1-11, (2012) Exhibit
Li, M. et al., “Importance of Glycosylation and Disulfide Bonds in Hyaluronidase Activity of Macaque Sperm Surface PH-20,” J Androl., 23(2):211-9 (2002) Exhibit
Reed et al., “Use of Coefficient of Variation in Assessing Variability of Quantitative Assays” Clin. Diagn. Lab Immunol. 9(6):1235-9 (2002) Exhibit
Murphy, K., “Janeway’s Immuno Biology,” (8th 2012), Chapters 1, 4, 8, 10, 11, 12, 15, and Appx I (Part 1) Exhibit
2024 Chemistry Nobel Prize Background Exhibit
Declaration of Jeffrey P. Kushan (Petitioner's Reply) Exhibit
Declaration of James Naismith, Ph.D. Exhibit
Fowler et al., “High-resolution mapping of protein sequence-function relationships” Nature Methods 7, 741–746 (2010) Exhibit
Cherr, G. et al., “The Dual Functions of GPI-Anchored PH-20: Hyaluronidase and Intracellular Signaling,” Matrix Biol., 20(8):515-25 (2001) Exhibit
Gregory Petsko, Ph.D. Deposition Transcript Exhibit
Gershoni, J. et al., “Epitope Mapping: The First Step in Developing Epitope-Based Vaccines,” BioDrugs, 21(3):145-56 (2007) Exhibit
Bolland, S., “An Innate Path to Human B Cell Tolerance,” Immunity, 29(5):667-9 (2008) Exhibit
Rolland, M. et al., “Recognition of HIV-1 Peptides by Host CTL Is Related to HIV-1 Similarity to Human Proteins,” PLoS One, 2(9):e823 (2007) Exhibit
Goodey, N. et al., “Allosteric Regulation and Catalysis Emerge via a Common Route,” Nat Chem Biol. 4(8):474-82 (2008) Exhibit
Ringe & Petsko, “Q&A: What are pharmacological chaperones and why are they interesting?” J. Biol. 8:80 (2009) Exhibit
Hirsch, C. et al., “The Ubiquitylation Machinery of the Endoplasmic Reticulum,” Nature, 458(7237):453-60 (2009) Exhibit
Martin-Deleon, “Epididymal SPAM1 and its Impact on Sperm Function” Molecular and Cellular Endocrinology 250:114-121 (2006) Exhibit
Dobson, “Experimental investigation of protein folding and misfolding” Methods 34(1):4-14 (2004) Exhibit
Ten Have et al., “Cloning and characterization of the cDNA encoding the PH20 protein in the European red fox Vulpes vulpes” Reprod. Fertil. Dev. 10(2):165-72 (1998) Exhibit
Dr. Naismith Analysis Spreadsheet Exhibit
Levine, B. and Levytska, V., “A Sensitive Hemagglutination Assay Method for Dinitrophenyl-Specific Antibodies. The Effect of Antibody Binding Affinity on Titers,” J Immunol., 98(3):648-52 (1967) Exhibit
Anderson, M. et al., “Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein,” Science, 298(5597):1395-401 (2002) Exhibit
Csoka, A. et al., “The Six Hyaluronidase-Like Genes in the Human and Mouse Genomes” Matrix Biology 20:499-508 (2001) Exhibit
Murphy, K., “Janeway’s Immuno Biology,” (8th 2012), Chapters 1, 4, 8, 10, 11, 12, 15, and Appx I (Part 2) Exhibit
Dobson, “Principles of protein folding, misfolding and aggregation” Semin. Cell. Dev. Biol. 15(1):3-16 (2004) Exhibit
Calloni et al., “Investigating the Effects of Mutations on Protein Aggregation in the Cell” J. Biol. Chem. 10607-13 (2005) Exhibit
Dunn, C. et al., “Transcription of the Human and Rodent SPAM1 / PH-20 Genes Initiates Within an Ancient Endogenous Retrovirus,” BMC Genomics, 6:47 (2005) Exhibit
Nolan et al., “The Safety of Recombinant Human Hyaluronidase PH20 in Nonclinical Models: An Overview of Toxicology, Pharmacology, and Impact of Anti-PH20 Antibodies,” Journal of Controlled Release, 374:369-383 (2024) Exhibit
Brachmann et al., “Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations” EMBO Journal 17:1847–59 (1998) Exhibit
Poelwijk, Frank J., et al., “Empirical fitness landscapes reveal accessible evolutionary paths” Nature 445.7126 (2007): 383-386 Exhibit
Siskind, G. and Eisen, H., “Effect of Variation in Antibody-Hapten Association Constant upon the Biologic Activity of the Antibody,” J Immunol., 95(3):436-41 (1965) Exhibit
Zhang, H. et al., “Mouse Spam1 (PH-20) Is a Multifunctional Protein: Evidence for Its Expression in the Female Reproductive Tract,” Biol Reprod., 69(2):446-54 (2003) Exhibit
Laver, W. et al., “Epitopes on Protein Antigens: Misconceptions and Realities,” Cell 61:553-556 (1990) Exhibit
Lu, X. et al., “Anti-gp160 IgG and IgA Antibodies Associated with a Large Increase in Total IgG in Cervicovaginal Secretions from Human Immunodeficiency Virus Type l-Infected Women,” Journal of Infectious Disease, 167(5):1189-92 (1993) Exhibit
Yewdell, J. et al., “Immunodominance in Major Histocompatibility Complex Class I-restricted T Lymphocyte Responses,” Annu. Rev. Immunol., 17:51–88 (1999) Exhibit
Kemp, T. et al., “Evaluation of Systemic and Mucosal Anti-HPV16 and Anti-HPV18 Antibody Responses from Vaccinated Women,” Vaccine, 26(29-30):3608-16 (2008) Exhibit
Leder, L. et al., “Genuine and Apparent Cross-Reaction of Polyclonal Antibodies to Proteins and Peptides,” Eur. J. Biochem. 219:73-81 (1994) Exhibit
Fauci, A. et al., “The Relationship between Antibody Affinity and the Efficiency of Complement Fixation,” J Immunol., 105(1):215-20 (1970) Exhibit
Dormitzer, P. et al., “Influenza Vaccine Immunology,” Immunol Rev., 239(1):167-77 (2011) Exhibit
Chiti & Dobson, “Protein Misfolding, Functional Amyloid, and Human Disease” Annu. Rev. Biochem. 75:333–66 (2006) Exhibit
Huo, Z. et al., “Systemic and Mucosal Immune Responses to Sublingual or Intramuscular Human Papilloma Virus Antigens in Healthy Female Volunteers,” PLoS ONE 7(3):e33736 (2012) Exhibit
Transcript of the Deposition of Dr. Gary Cherr, Ph.D., November 12, 2025 Exhibit
AutoDock Vina Tutorial 2011 Exhibit
Chowpongpang et al., “Cloning and characterization of the bovine testicular PH-20 hyaluronidase core domain” Biotechnol. Lett. 26(15):1247-52 (2004) Exhibit
Redwood, A. et al., “Viral Vectored Immunocontraception: Screening of Multiple Fertility Antigens using Murine Cytomegalovirus as a Vaccine Vector,” Vaccine, 25(4):698-708 (2007) Exhibit
Im, S. et al., “Cryo-EM Structure of Human Hyaluronidase PH-20,” Proteins: Structure, Function, and Bioinformatics 93:1067-1073 (2025) Exhibit
Yang, X. et al., “An Introduction to Epitope Prediction Methods and Software,” Rev. Med. Virol., 19: 77–96 (2009) Exhibit
Russell, M. et al., “Complement-Fixing Properties of Human IgA Antibodies. Alternative Pathway Complement Activation by Plastic-Bound, but not Specific Antigen-Bound, IgA,” Scand J Immunol., 30(2):175-83 (1989) Exhibit
Pal et al., “Comprehensive and Quantitative Mapping of Energy Landscapes for Protein-Protein Interactions by Rapid Combinatorial Scanning” J. Biol. Chem. 4;281(31):22378-22385 (2006) Exhibit
Emails re: AutoDock Vina (Sept. 9, 2025 - Oct. 27, 2025) Exhibit
Farber & Petsko, “The evolution of alpha/beta barrel enzymes” Trends Biochem. Sci. 15(6):228-34 (1990) Exhibit
Petitioner's Reply to Patent Owner's Response REPLYTOOPP
Ochoa-Levya et al., “Protein Design through Systematic Catalytic Loop Exchange in the (beta/alpha)8 Fold” J. Mol. Biol. 10 387(4):949-64 (2009) Exhibit
Printz, M. et al., “Risk Factors, Hyaluronidase Expression, and Clinical Immunogenicity of Recombinant Human Hyaluronidase PH20, an Enzyme Enabling Subcutaneous Drug Administration,” AAPS 24(6):110 (2022) Exhibit
Chiti et al., “Rationalization of the effects of mutations on peptide and protein aggregation rates” Nature, 424:805-808 (2003) Exhibit
Declaration of Dr. Garnett Kelsoe Exhibit
Montefiori, D. et al., “Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials,” Journal of Infectious Disease, 206(3):431-41 (2012) Exhibit
Singh, S., et al., “Solubilization and Refolding of Bacterial Inclusion Body Proteins,” Journal of Bioscience and Bioengineering 99:303-310 (2005) Exhibit
CDC on H5N1 CDC Press Release: “Highly Pathogenic Avian Influenza A (H5N1) Virus Infection Reported in a Person in the U.S.” (Apr. 1, 2024) Exhibit
Rodriguez, L. et al., “Foot and mouth disease virus vaccines,” Vaccine 27:D90-D94 (2009) Exhibit
McCutcheon, J. et al., “HLA-B*0702 Antibody Epitopes are Affected Indirectly by Distant Antigen Residues,” Hum Immunol., 36(2):69-75 (1993) Exhibit
Dobson, “Protein misfolding, evolution and Disease” Trends Biochem. Sci. (9):329-32 (1999) Exhibit
Nelson, C. et al., “Peptides Determine the Lifespan of MHC Class II Molecules in the Antigen-Presenting Cell,” Nature, 371(6494):250-2 (1994) Exhibit
Popova, L. et al., “Immunodominance of Antigenic Site B over Site A of Hemagglutinin of Recent H3N2 Influenza Viruses,” PLoS One, 7(7):e41895 (2012) Exhibit
Goldsmith & Tawfik, “Directed enzyme evolution: beyond the low-hanging fruit” Curr. Opin. Struct. Biol. 22(4):406-12 (2012) Exhibit
Transcript of the Deposition of Dr. James Moon, Ph.D., November 18, 2025 Exhibit
Petsko, “Herding CATS” Sci. Transl. Med. 24;3(97):97 (2011) Exhibit
Koch, C. et al., “A Comparison of the Immunogenicity of the Native and Denatured Forms of a Protein,” APMIS 104:115-125 (1996) Exhibit
Mantis, NJ., et al., “Secretory IgA ’ s Complex Roles in Immunity and Mucosal Homeostasis in the Gut,” Mucosal Immunol., 4(6):603-11 (2011) Exhibit
Nobusawa, E. et al., “Comparison of Complete Amino Acid Sequences and Receptor-Binding Properties among 13 Serotypes of Hemagglutinins of Influenza A Viruses,” Virology, 182(2):475-85 (1991) Exhibit
Nagano et al., “One Fold with Many Functions: The Evolutionary Relationships between TIM Barrel Families Based on their Sequences, Structures and Functions” J. Mol. Biol. 30;321(5):741-65 (2002) Exhibit
Second Table Associating Citations from the ’590 Patent (EX1001) to Corresponding Citations in the ’731 Application (EX1026) Exhibit
Dobson, “Protein folding and misfolding” Nature. 18;426(6968):884-90 (2003) Exhibit
Melanie Ann Simpson, Ph.D. Deposition Transcript Exhibit
Petitioner's Request for Oral Argument OTHER
Patent Owner's Request for Oral Argument OTHER
Petitioner's Supplemental Brief in Opposition to Patent Owner's Motion to Terminate OTHER
Petitioner's Fourth Motion to Seal MOTION
Patent Owner's Fifth Motion to Seal MOTION
Petitioner's Updated Exhibit List NOTICE
Patent Owner's Notice of Grez Deposition NOTICE
Order: Granting Petitioner's Motion to Seal ORDER
Petitioner's Third Motion to Seal MOTION
Declaration of Kelly Grez Exhibit
Petitioner's Updated Exhibit List NOTICE
Patent Owner's Motion to Terminate (PUBLIC - UPDATED REDACTIONS) OTHER
Order Conduct of the Proceedings ORDER
Order: Granting Petitioner's Motion to Seal ORDER
ORDER Granting Patent Owner’s Motion to Seal 37 C.F.R. §§ 42.14, 42.54 ORDER
Patent Owner's Reply in Support of Motion to Terminate (PUBLIC - REDACTED) OTHER
Patent Owner's Third Motion to Seal MOTION
Order: ORDER Conditionally Granting Patent Owner’s Motion to Seal 37 C.F.R. §§ 42.14, 42.54 ORDER
State of New Jersey, Certificate of Long Form Standing with Officers and Directors, Merck Sharp & Dohme LLC (Feb. 18, 2026) Exhibit
Merck & Co., Inc., Form 8-K (Nov. 4, 2009 Exhibit
MSD Netherlands Capital B.V., Preliminary Prospectus Supplement (May 14, 2024) Exhibit
Table Comparing the Boards of Directors for Merck & Co., Inc. and Merck Sharp & Dohme LLC Exhibit
Company Statement: “Merck Sues Merck KGaA, Darmstadt, Germany for Improper Use of “Merck”” (Jan. 15, 2016) Exhibit
Press Release: “Merck and Schering-Plough to Merge” (Mar. 9, 2009) Exhibit
Merck & Co., Inc. Subsidiaries (Dec. 31, 2024 Exhibit
State of New Jersey, Certificate of Long Form Standing with Officers and Directors, Merck & Co., Inc. (Feb. 18, 2026) Exhibit
Petitioner's Updated Exhibit List NOTICE
Petitioner's Opposition to Patent Owner's Motion to Terminate OPPOSITION
Petitioner's Motion to Seal MOTION
EX2401 - E-mail (PUBLIC - REDACTED) Exhibit
Patent Owner's Updated Exhibit List NOTICE
Patent Owner's Second Motion to Seal MOTION
EX2451 - Employment Letter Exhibit
EX2459 - NJ Rules of Professional Conduct Exhibit
EX2465 - Merck OED Search Exhibit
Patent Owner's Motion to Terminate (Public) MOTION
EX2464 - SEC Form 13F Exhibit
Patent Owner's Updated Exhibit List NOTICE
EX2454 - Merck Co June 2025 Form 10-Q Exhibit
EX2466 - Merck Form 8K Exhibit
EX2456 - Merck 2024 Form 10K Exhibit 24.1 Exhibit
EX2453 - 2025-09-30 MSD SEC FORM 13F-NT Exhibit
EX2461 - OED Search Exhibit
EX2457 - Sarbanes-Oxley Act 2002 Exhibit
EX2460 - MSD Bio Exhibit
EX2449 - LinkedIn Exhibit
EX2463 - 2025 Merck Schedule 14A Proxy Statement Exhibit
EX2446 - Amicus Brief Exhibit
EX2452 - 2025-09-30 Merck Co SEC FORM 13F-HR Exhibit
EX2462 - 2024 MSD LLC Schedule 13D Exhibit
EX2458 - Merck Co Bio Exhibit
EX2450 - OED PTO Form 158 Exhibit
EX2467 - Merck Form 8K Exhibit 99.1 - Press Release Exhibit
EX2447 - IPO Board of Directors Exhibit
EX2448 - ChIPs - Speaker Details Exhibit
EX2468 - Exhibit 99.2 to Form 8-K, Merck and Co. Inc., February 3, 2026 Exhibit
ORDER Conduct of the Proceedings 37 C.F.R. § 42.5 ORDER
EX 3002 Exhibit
Order: Denying Patent Owners Motion for Additional Discovery 37 C.F.R. sec. 42.51 ORDER
Order: Granting Motion to Seal ORDER
Ex. 3001 Attorney Correspondence Exhibit
Order: Conduct of Proceeding ORDER
MERCK_PGR00090 - DNJ-2-25-cv-03179 2025-07-14 [019] Corporate Disclosure Statement Exhibit
MERCK_PGR00094 - DNJ-2-25-cv-03179 Stipulation to Substitute Parties Exhibit
Petitioner's Opposition to Patent Owner's Motion for Additional Discovery OPPOSITION
MERCK_PGR00458 - PTAB-PGR2021-00036-16 Merck- Genentech PGR Exhibit
MERCK_PGR00462 - RE_ 2_25-cv-03179-ES-JRA_ HALOZYME, INC. v. MERCK SHARP & DOHME CORP. Exhibit
MERCK_PGR00355 - PTAB-PGR2021-00036-1 Merck- Genentech PGR Exhibit
EX2091 - Davies 1995 Exhibit
EX2111 - Yudin BOR 2005 Exhibit
EX2108 - Hunnicutt 1996 Exhibit
EX2149 - Rhorer 2009 Exhibit
EX2099 - Takahashi 2003 Exhibit
EX2114 - Frayne 1999 Exhibit
EX2083 - Assay Guidance Manual (Part 4 of 6) Exhibit
EX2074 - Moon Declaration Exhibit
EX2126 - Suri 2005 Exhibit
EX2078 - Park Deposition Transcript 2025-08-21 Exhibit
EX2166 - Petsko Patent Analysis Data Exhibit
EX2138 - Rhee 2012 Exhibit
EX2179 - 1FCV pdb file Exhibit
EX2087 - Lu 2025 Exhibit
EX2190 - L307Y Swiss Model Exhibit
EX2189 - L307W Swiss Model Exhibit
EX2150 - Mielcarek 2000 Exhibit
Patent Owner's Response RESPONSE
EX2121 - Ganesan 2010 Exhibit
EX2077 - Park Deposition Transcript 2025-08-07 Exhibit
Download Proceeding Documents
Case PGR2025-00024 • 200 documents
Preparing ZIP Archive
Email verified! Bundling proceeding documents from USPTO. Your download will start automatically in a few seconds...